Prof. Sheng-Ying Qin, PhD
Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
Special Issue Introduction
Personalized medicine understands the disease with molecular perspectives, which has brought new classified systems and more effectively preventive and therapeutic interventions. It aims to precisely categorize diseases and their subtypes so that applicable treatments can be improved to a patient's distinctive molecular profile and physiology. Pharmacogenomics plays a critical role in an evolving model of personalized medicine. It is well known that response to medications and side effects is different in every single patient. The inter-individual variability seems to explain these differences which are mainly based on the individual genomic sequence. It possesses the potential that treatment will be tailored to each individual patient in the future. Although genomic testing is still a relatively new development in clinical treatment, this field is expanding. The Special Issue about Personalized Genomic Medicine focuses on the studies about genetics, genomics, pharmacogenomics etc., which may improve the efficacy and safety of individualized clinical treatment. This Special Issue welcomes articles in the forms of original research, reviews and evaluations of discoveries about personalized medicine.
Personalized medicine, genomic medicine, precision medicine, pharmacogenomics, targeted therapy, human disease
30 Jun 2018